Skip to main content
Clinical Trials/NCT04790604
NCT04790604
Completed
N/A

Enhancing Community Health Through Patient Navigation, Advocacy and Social Support (ENCOMPASS): Expansion Study A, A Randomized Controlled Trial With Waitlist Control

University of Calgary1 site in 1 country96 target enrollmentJanuary 22, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hypertension
Sponsor
University of Calgary
Enrollment
96
Locations
1
Primary Endpoint
Acute care service use
Status
Completed
Last Updated
last year

Overview

Brief Summary

Some patients living with multiple long-term health conditions have difficulty accessing the services they need, despite available primary care and community resources. Patient navigation programs may help those with complex health conditions to improve their care and outcomes. Community health navigators (CHNs) are community members who help guide patients through the health care system. CHNs are not health professionals like a doctor or nurse, but they are specially trained to help patients get the most out of their health care and connect them to resources. The ENCOMPASS program of research evaluates a patient navigation program that connects patients living with long-term health conditions to CHNs. To understand if the CHN program can be scaled to a provincial level, the ENCOMPASS program of research is expanding to select primary care settings across Alberta. This study implements and evaluates the CHN program at Edmonton Oliver Primary Care Network in Edmonton, Alberta, Canada.

Detailed Description

Community Health Navigators (CHNs) are defined as community health workers that provide patient navigation. Based on evidence to date, CHNs for chronic disease management are likely to beneficially impact patient experience, clinical outcomes and costs; however, contextual evidence is lacking given that most studies to date have been conducted in the United States. In Canada, patient navigation programs currently exist in only a few settings (primarily cancer treatment and transitional care), with few navigation programs implemented in chronic disease care. The ENCOMPASS program of research was initiated in 2016, when researchers with the University of Calgary's Interdisciplinary Chronic Disease Collaboration partnered with Mosaic Primary Care Network (PCN) to develop, implement and evaluate a community health navigation program for patients with multiple chronic conditions. The program was based on a systematic literature review and refined in consultation with key stakeholders. A cluster-randomized controlled trial is currently ongoing with Mosaic PCN to determine the impact of the program on acute care use, patient-reported outcomes and experience, and disease-specific clinical outcomes (NCT03077386). Alberta Primary Care Networks (PCNs) are comprised of groups of family physicians and other health care professionals working together to provide comprehensive patient care to Albertans. To understand if the community health navigation program can be feasibly scaled and spread to PCNs across Alberta, we are expanding research to examine and evaluate community health navigation program implementation to other geographic areas and populations. This study expands the ENCOMPASS program of research to Edmonton Oliver PCN, which represents over 170 physician members and serves approximately 131,000 patients. The current study employs the RE-AIM framework (reach, effectiveness, adoption, implementation, and maintenance) to examine the scalability of the community health navigation program. The objectives of this study are to (1) assess the impact of the intervention on the target population and health system (effectiveness); (2) explore the feasibility and appropriateness of practical intervention scale-up (reach, adoption, implementation, and maintenance), and (3) identify the required resources and infrastructure necessary to maintain and scale the intervention provincially. The effectiveness of the community health navigator program will be studied using a two-armed, pragmatic, randomized waitlist-controlled trial. This study will employ patient-level block randomization with research staff blinded to block size. Randomization will be concealed and computer-generated. Primary outcomes will be assessed using administrative health data. Secondary outcomes will be measured using a patient health survey administered by a research assistant at baseline, 6 months, and 12 months. A concurrent qualitative study will provide contextual information on the effectiveness of the community health navigator program from patient, provider, and CHN perspectives. Process evaluation metrics and interviews with program stakeholders will inform the feasibility and sustainability of the community health navigator program in Alberta PCNs.

Registry
clinicaltrials.gov
Start Date
January 22, 2021
End Date
July 3, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Poorly controlled hypertension (most recent systolic blood pressure \> 160 mmHg or labile);
  • Poorly controlled diabetes (A1C \> 9% on at least one occasion within the past year or labile);
  • Stage 3b or greater chronic kidney disease (estimated glomerular filtration rate \< 45 mL/min/1.73m2 in past year);
  • Established ischemic heart disease (at least one instance of a physician billing diagnosis with a relevant International Classification of Diseases, 9th Edition \[ICD-9\] code recorded in electronic medical record (EMR), or known to health care team);
  • Congestive heart failure (at least one instance of a physician billing diagnosis with a relevant ICD-9 code recorded in EMR, or known to health care team);
  • Chronic obstructive pulmonary disease OR Asthma with at least two visits in the past year (at least 2 instances of a physician billing diagnosis with a relevant ICD-9 code, or known to health care team).

Exclusion Criteria

  • Patient unable to provide informed consent;
  • Patient residing in long-term care facility;
  • Health care provider discretion.

Outcomes

Primary Outcomes

Acute care service use

Time Frame: Up to 36 months

Rate of emergency department visits and hospital admissions based on administrative health data.

Secondary Outcomes

  • Anxiety symptoms(Up to 12 months)
  • Perceived social support(Up to 12 months)
  • Health literacy(Up to 12 months)
  • Program costs(Up to 24 months)
  • Acute care costs(Up to 24 months)
  • Patient experience of care(Up to 12 months)
  • Patient activation(Up to 12 months)
  • General self-rated health(Up to 12 months)
  • Smoking status(Up to 12 months)
  • Disease-specific intermediate health outcomes: Hypertension(Up to 12 months)
  • Health-related quality of life(Up to 12 months)
  • Weight(Up to 12 months)
  • Disease-specific intermediate health outcomes: COPD/asthma(Up to 24 months)
  • Primary Care Network (PCN) multidisciplinary team access(Up to 24 months)
  • Depressive symptoms(Up to 12 months)
  • Household food security(Up to 12 months)
  • Disease-specific intermediate health outcomes: Ischemic heart disease, chronic kidney disease, diabetes(Up to 24 months)
  • Provider satisfaction(Up to 12 months)
  • Continuity of care(Up to 24 months)
  • Physician costs(Up to 24 months)
  • All-cause mortality(Up to 24 months)
  • Medication adherence(Up to 24 months)
  • Disease-specific intermediate health outcomes: Diabetes(Up to 24 months)
  • Disease-specific intermediate health outcomes: Heart failure(Up to 24 months)
  • Patient experience(Up to 12 months)

Study Sites (1)

Loading locations...

Similar Trials